TriHealth Inc.
trihealth.comTotal trials
102
Active
10
Phase 3
6
Total enrollment
40,535
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Pro-Nox Nitrous Oxide/Oxygen Delivery System | — | — | — | — | — | 1 | |
| Standard Care for Bladder Botox | — | — | — | — | — | 1 | |
| Tamsulosin | — | — | — | — | — | 1 | |
| Estradiol 0.01% Vag Cream | — | — | — | — | — | 1 | |
| testosterone 0.1% and estradiol 0.01% vaginal cream | — | — | — | — | — | 1 |
Next readouts
- 2026-02-01
- 2026-07
- 2026-11
Top conditions
- Pelvic Organ Prolapse14
- Pain, Postoperative5
- Postoperative Pain3
- Overactive Bladder3
- Arthroplasty, Replacement, Knee3
- Obstetric Trauma2
- Deep Vein Thrombosis2
- Cesarean Section2
Frequently asked questions about TriHealth Inc.
- How many clinical trials does TriHealth Inc. have on ClinicalTrials.gov?
- TriHealth Inc. is listed as the lead sponsor on 102 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of TriHealth Inc.'s trials are in Phase 3?
- 6 of TriHealth Inc.'s trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does TriHealth Inc. focus on?
- TriHealth Inc.'s most-studied conditions on ClinicalTrials.gov are Pelvic Organ Prolapse, Pain, Postoperative, Postoperative Pain, Overactive Bladder, Arthroplasty, Replacement, Knee.
- When are TriHealth Inc.'s next clinical trial readouts?
- TriHealth Inc. has 3 upcoming primary-completion readouts tracked here; the soonest is “Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery”, expected around 2026-02-01.